Atlas Trials

Safety and Immunogenicity of HIV DNA-C CN54ENV and Recombinant HIV CN54gp140 Vaccines in Healthy Volunteers

Clinical trial NCT02589795 · COMPLETED

Trial details

NCT number
NCT02589795
Sponsor
Imperial College London
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
HIV
Start date
2016-08-11
Primary completion
2017-12-22
Enrollment
28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.